GLP-1 medications are reshaping why people walk through your doors, and what they expect when they do. We’ll explore how gyms, studios and clubs are responding with medical partnerships, habit coaching, adaptive programming that complements pharmacological weight loss and more. Walk away with actionable strategies to stay relevant, retain members, and create new revenue streams in this fast-evolving health landscape.
Tracy J Sims
Tracy Sims is Executive Director, Cardiometabolic Health Corporate Affairs at Eli Lilly and Company. He leads health system analysis and policy modernization efforts for chronic diseases including obesity and diabetes. Tracy’s role includes real-world evidence research, and he has authored papers in both obesity and diabetes care. He is an ex-officio member of the National Academies of Sciences, Engineering, and Medicine serving on the Roundtable On Obesity Solutions. Tracy holds a Master of Arts in Sociology from the University of Alabama at Birmingham.